Please enable JavaScript to continue using this application.

Compare $AKBA vs $ALEC | Chartloom

Compare

$AKBA vs $ALEC

Akebia Therapeutics Inc · Alector Inc

AKBA

Akebia Therapeutics Inc

ALEC

Alector Inc

Compare $AKBA vs $ALEC

Comparing Akebia Therapeutics Inc and Alector Inc

AKBAAkebia Therapeutics Inc

ALECAlector Inc

AKBAAkebia Therapeutics Inc

Market cap

$215M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.35x

Rev growth (TTM)

7.5%

YTD performance

-48.3%

52W performance

-71.9%

FCF yield

13.7%

ALECAlector Inc

Market cap

$231M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

34.29x

Rev growth (TTM)

-82.9%

YTD performance

35.9%

52W performance

-32.5%

FCF yield

-68.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AKBA

ALEC

Detailed metrics comparison

AKBA

Akebia Therapeutics Inc

ALEC

Alector Inc

Market Cap

AKBA$215M

ALEC$231M

Enterprise Value

AKBA$252M

ALEC$181M

Price

AKBA$0.80

ALEC$2.08

P/E Ratio

AKBAN/A

ALECN/A

P/S Ratio

AKBA0.98x

ALEC16.66x

EV/Sales

AKBA1.15x

ALEC13.05x

EV/EBITDA

AKBA49.22x

ALEC3.60x

P/B Ratio

AKBA9.58x

ALEC19.47x

P/FCF Ratio

AKBA7.30x

ALECN/A

EV/FCF

AKBA8.54x

ALEC-1.14x

PEG Ratio

AKBAN/A

ALECN/A

Forward P/E (NTM)

AKBAN/A

ALECN/A

Forward P/S (NTM)

AKBA1.35x

ALEC34.29x

Revenue (TTM)

AKBA$219M

ALEC$14M

Revenue Growth (YoY)

AKBA7.5%

ALEC-82.9%

Forward Rev Growth

AKBA-33.0%

ALEC281.0%

Gross Margin (TTM)

AKBA81.5%

ALEC0.0%

Operating Margin (TTM)

AKBA0.0%

ALEC0.0%

EBITDA Margin (TTM)

AKBA-1.9%

ALEC-879.7%

Net Margin (TTM)

AKBA-13.5%

ALEC-850.1%

FCF Margin (TTM)

AKBA13.4%

ALEC-1142.6%

Net Income (TTM)

AKBA$-30M

ALEC$-118M

FCF (TTM)

AKBA$29M

ALEC$-158M

EPS (TTM)

AKBA-$0.11

ALEC-$1.06

ROE (TTM)

AKBA-9374.0%

ALEC-29517.0%

ROA (TTM)

AKBA-817.0%

ALEC-4400.0%

ROIC (TTM)

AKBA-1321.0%

ALEC-24053.0%

Cash

AKBA$156M

ALEC$60M

Debt

AKBA$192M

ALEC$10M

Net Cash/Debt

AKBA$-37M

ALEC$50M

Current Ratio (TTM)

AKBA1.43x

ALEC5.26x

Quick Ratio (TTM)

AKBA1.31x

ALEC5.05x

Debt/Equity (TTM)

AKBA7.69x

ALEC0.94x

Debt/Assets (TTM)

AKBA0.0%

ALEC0.0%

Interest Coverage (TTM)

AKBAN/A

ALECN/A

Net Debt/EBITDA (TTM)

AKBA0.00x

ALEC0.00x

Beta

AKBA0.20

ALEC0.65

52W Performance

AKBA-71.9%

ALEC-32.5%

YTD Performance

AKBA-48.3%

ALEC35.9%

% from 52W High

AKBA-75.0%

ALEC-38.8%

% from 52W Low

AKBA0.0%

ALEC90.8%

Asset Turnover (TTM)

AKBA0.60x

ALEC0.05x

FCF Yield (TTM)

AKBA13.7%

ALEC-68.6%

Earnings Yield (TTM)

AKBA-13.8%

ALEC-51.0%

Dividend Yield (TTM)

AKBAN/A

ALECN/A

Rule of 40

AKBA21.0

ALEC-1,225.5

EV/GP/RG

AKBAN/A

ALECN/A

Ticker research

View AKBA research View ALEC research

Metric	AKBA Akebia Therapeutics Inc	ALEC Alector Inc
Market & Valuation
Market Cap	$215M	$231M
Enterprise Value	$252M	$181M
Price	$0.80	$2.08
P/E Ratio	N/A	N/A
P/S Ratio	0.98x	16.66x
EV/Sales	1.15x	13.05x
EV/EBITDA	49.22x	3.60x
P/B Ratio	9.58x	19.47x
P/FCF Ratio	7.30x	N/A
EV/FCF	8.54x	-1.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.35x	34.29x
Revenue & Growth
Revenue (TTM)	$219M	$14M
Revenue Growth (YoY)	7.5%	-82.9%
Forward Rev Growth	-33.0%	281.0%
Profitability
Gross Margin (TTM)	81.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-879.7%
Net Margin (TTM)	-13.5%	-850.1%
FCF Margin (TTM)	13.4%	-1142.6%
Net Income (TTM)	$-30M	$-118M
FCF (TTM)	$29M	$-158M
EPS (TTM)	-$0.11	-$1.06
ROE (TTM)	-9374.0%	-29517.0%
ROA (TTM)	-817.0%	-4400.0%
ROIC (TTM)	-1321.0%	-24053.0%
Financial Health
Cash	$156M	$60M
Debt	$192M	$10M
Net Cash/Debt	$-37M	$50M
Current Ratio (TTM)	1.43x	5.26x
Quick Ratio (TTM)	1.31x	5.05x
Debt/Equity (TTM)	7.69x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.20	0.65
52W Performance	-71.9%	-32.5%
YTD Performance	-48.3%	35.9%
% from 52W High	-75.0%	-38.8%
% from 52W Low	0.0%	90.8%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.05x
FCF Yield (TTM)	13.7%	-68.6%
Earnings Yield (TTM)	-13.8%	-51.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	21.0	-1,225.5
EV/GP/RG	N/A	N/A
Ticker research	View AKBA research	View ALEC research

Valuation

P/S Ratio

AKBA

0.98x

ALEC

16.66x

EV/FCF

ALEC

-1.14x

AKBA

8.54x

Growth & revenue

Revenue Growth TTM

AKBA

7.5%

ALEC

-82.9%

Forward Revenue Growth

ALEC

281.0%

AKBA

-33.0%

Profitability & performance

Gross Margin

AKBA

81.5%

ALEC

0.0%

ROE

AKBA

-9374.0%

ALEC

-29517.0%

FCF Yield %

AKBA

13.7%

ALEC

-68.6%

52-Week Performance

ALEC

-32.5%

AKBA

-71.9%

Detailed metrics comparison

AKBA

Akebia Therapeutics Inc

ALEC

Alector Inc

Market Cap

AKBA$215M

ALEC$231M

Enterprise Value

AKBA$252M

ALEC$181M

Price

AKBA$0.80

ALEC$2.08

P/E Ratio

AKBAN/A

ALECN/A

P/S Ratio

AKBA0.98x

ALEC16.66x

EV/Sales

AKBA1.15x

ALEC13.05x

EV/EBITDA

AKBA49.22x

ALEC3.60x

P/B Ratio

AKBA9.58x

ALEC19.47x

P/FCF Ratio

AKBA7.30x

ALECN/A

EV/FCF

AKBA8.54x

ALEC-1.14x

PEG Ratio

AKBAN/A

ALECN/A

Forward P/E (NTM)

AKBAN/A

ALECN/A

Forward P/S (NTM)

AKBA1.35x

ALEC34.29x

Revenue (TTM)

AKBA$219M

ALEC$14M

Revenue Growth (YoY)

AKBA7.5%

ALEC-82.9%

Forward Rev Growth

AKBA-33.0%

ALEC281.0%

Gross Margin (TTM)

AKBA81.5%

ALEC0.0%

Operating Margin (TTM)

AKBA0.0%

ALEC0.0%

EBITDA Margin (TTM)

AKBA-1.9%

ALEC-879.7%

Net Margin (TTM)

AKBA-13.5%

ALEC-850.1%

FCF Margin (TTM)

AKBA13.4%

ALEC-1142.6%

Net Income (TTM)

AKBA$-30M

ALEC$-118M

FCF (TTM)

AKBA$29M

ALEC$-158M

EPS (TTM)

AKBA-$0.11

ALEC-$1.06

ROE (TTM)

AKBA-9374.0%

ALEC-29517.0%

ROA (TTM)

AKBA-817.0%

ALEC-4400.0%

ROIC (TTM)

AKBA-1321.0%

ALEC-24053.0%

Cash

AKBA$156M

ALEC$60M

Debt

AKBA$192M

ALEC$10M

Net Cash/Debt

AKBA$-37M

ALEC$50M

Current Ratio (TTM)

AKBA1.43x

ALEC5.26x

Quick Ratio (TTM)

AKBA1.31x

ALEC5.05x

Debt/Equity (TTM)

AKBA7.69x

ALEC0.94x

Debt/Assets (TTM)

AKBA0.0%

ALEC0.0%

Interest Coverage (TTM)

AKBAN/A

ALECN/A

Net Debt/EBITDA (TTM)

AKBA0.00x

ALEC0.00x

Beta

AKBA0.20

ALEC0.65

52W Performance

AKBA-71.9%

ALEC-32.5%

YTD Performance

AKBA-48.3%

ALEC35.9%

% from 52W High

AKBA-75.0%

ALEC-38.8%

% from 52W Low

AKBA0.0%

ALEC90.8%

Asset Turnover (TTM)

AKBA0.60x

ALEC0.05x

FCF Yield (TTM)

AKBA13.7%

ALEC-68.6%

Earnings Yield (TTM)

AKBA-13.8%

ALEC-51.0%

Dividend Yield (TTM)

AKBAN/A

ALECN/A

Rule of 40

AKBA21.0

ALEC-1,225.5

EV/GP/RG

AKBAN/A

ALECN/A

Ticker research

View AKBA research View ALEC research

Metric	AKBA Akebia Therapeutics Inc	ALEC Alector Inc
Market & Valuation
Market Cap	$215M	$231M
Enterprise Value	$252M	$181M
Price	$0.80	$2.08
P/E Ratio	N/A	N/A
P/S Ratio	0.98x	16.66x
EV/Sales	1.15x	13.05x
EV/EBITDA	49.22x	3.60x
P/B Ratio	9.58x	19.47x
P/FCF Ratio	7.30x	N/A
EV/FCF	8.54x	-1.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.35x	34.29x
Revenue & Growth
Revenue (TTM)	$219M	$14M
Revenue Growth (YoY)	7.5%	-82.9%
Forward Rev Growth	-33.0%	281.0%
Profitability
Gross Margin (TTM)	81.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-879.7%
Net Margin (TTM)	-13.5%	-850.1%
FCF Margin (TTM)	13.4%	-1142.6%
Net Income (TTM)	$-30M	$-118M
FCF (TTM)	$29M	$-158M
EPS (TTM)	-$0.11	-$1.06
ROE (TTM)	-9374.0%	-29517.0%
ROA (TTM)	-817.0%	-4400.0%
ROIC (TTM)	-1321.0%	-24053.0%
Financial Health
Cash	$156M	$60M
Debt	$192M	$10M
Net Cash/Debt	$-37M	$50M
Current Ratio (TTM)	1.43x	5.26x
Quick Ratio (TTM)	1.31x	5.05x
Debt/Equity (TTM)	7.69x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.20	0.65
52W Performance	-71.9%	-32.5%
YTD Performance	-48.3%	35.9%
% from 52W High	-75.0%	-38.8%
% from 52W Low	0.0%	90.8%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.05x
FCF Yield (TTM)	13.7%	-68.6%
Earnings Yield (TTM)	-13.8%	-51.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	21.0	-1,225.5
EV/GP/RG	N/A	N/A
Ticker research	View AKBA research	View ALEC research